SCHEMBL31273809

SCHEMBL31273809

Cc1cc(-c2cc(C#N)c(-n3c4ccc(-n5c6ccccc6c6ccccc65)cc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)cc2-n2c3ccc(-n4c5ccccc5c5ccccc54)cc3c3cc(-n4c5ccccc5c5ccccc54)ccc32)cc(C)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.36
HPGD P15428 8/20 0.36
MAPK1 P28482 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 9/20 0.33
GAA P10253 4/20 0.33
HSD17B10 Q99714 5/20 0.33
GLA P06280 3/20 0.33
CASP1 P29466 2/20 0.32
RECQL P46063 1/20 0.32
CASP7 P55210 1/20 0.32
IMPDH2 P12268 1/20 0.32
S1PR4 O95977 1/20 0.32
S1PR1 P21453 1/20 0.32
NR3C1 P04150 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273488 1.00 ALDH1A1 (0.36) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL19913222 0.90 ALDH1A1 (0.36) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL19909182 0.90 ALDH1A1 (0.36) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL31273726 0.88 CYP1A2 (0.40) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL31272917 0.86 MAPK1 (0.38) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL22170373 0.83 ALDH1A1 (0.36) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL21414221 0.83 KDM4E (0.33) ALDH1A1HPGDMAPK1LMNASMN1; SMN2
SCHEMBL31273401 0.83 PTGER4 (0.34) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL19913223 0.82 MAPK1 (0.38) ALDH1A1HPGDMAPK1CYP1A2CYP2C9
SCHEMBL19909513 0.82 MAPK1 (0.38) ALDH1A1HPGDMAPK1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-11-20 US disclosed
US-12369492-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2025-07-22 US disclosed
EP-4498784-A2 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2025-01-29 EP disclosed
EP-3775100-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250359476-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885HPGD 2163/4885MAPK1 4873/4885
US-12369492-B2 Composition of matter for use in organic light-emitting diodes CRY2, SLCO1B3, NDUFV3 ALDH1A1 242/4885HPGD 2163/4885MAPK1 4873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.